Literature DB >> 33622890

Homozygosity for rs17775810 Minor Allele Associated With Reduced Mortality of COVID-19 in the UK Biobank Cohort.

Steven Lehrer1, Peter H Rheinstein2.   

Abstract

BACKGROUND/AIM: Adult outpatients with symptomatic COVID-19 treated with fluvoxamine, compared with placebo, had a lower likelihood of clinical deterioration over 15 days. Fluvoxamine strongly binds to the sigma-1 receptor (S1R) that regulates inflammation by inhibiting the production of cytokines, believed to be responsible for severe COVID-19. We evaluated the S1R locus on chr 9p13.3 in subjects tested positive for SARS-CoV-2. We focused on SNP rs17775810 that has been previously identified by examining loss-of-function mutations in the S1R gene associated with distal hereditary motor neuropathy. PATIENTS AND METHODS: We utilized UK Biobank (UKB) data. Data processing was performed on Minerva, a Linux mainframe with Centos 7.6, at the Icahn School of Medicine at Mount Sinai.
RESULTS: The effect of rs17775810 genotype on survival was significant (p=0.036, 2 tailed Fisher exact test). The minor allele homozygotes (TT) had the lowest death rate (0%), whereas the non-TT genotypes (i.e. CT and CC) had the highest death rate (16.2%).
CONCLUSION: The rs17775810 analysis corroborates the favorable effect of fluvoxamine on COVID-19 survival. Copyright
© 2021, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  COVID-19; S1r; allele; fluvoxamine; motor neuropathy

Mesh:

Substances:

Year:  2021        PMID: 33622890      PMCID: PMC8045077          DOI: 10.21873/invivo.12338

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  14 in total

1.  Loss-of-function mutations in the SIGMAR1 gene cause distal hereditary motor neuropathy by impairing ER-mitochondria tethering and Ca2+ signalling.

Authors:  Elisa Gregianin; Giorgia Pallafacchina; Sofia Zanin; Valeria Crippa; Paola Rusmini; Angelo Poletti; Mingyan Fang; Zhouxuan Li; Laura Diano; Antonio Petrucci; Ludovico Lispi; Tiziana Cavallaro; Gian M Fabrizi; Maria Muglia; Francesca Boaretto; Andrea Vettori; Rosario Rizzuto; Maria L Mostacciuolo; Giovanni Vazza
Journal:  Hum Mol Genet       Date:  2016-07-08       Impact factor: 6.150

2.  Found: genes that sway the course of the coronavirus.

Authors:  Jocelyn Kaiser
Journal:  Science       Date:  2020-10-16       Impact factor: 47.728

3.  Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19: A Randomized Clinical Trial.

Authors:  Eric J Lenze; Caline Mattar; Charles F Zorumski; Angela Stevens; Julie Schweiger; Ginger E Nicol; J Philip Miller; Lei Yang; Michael Yingling; Michael S Avidan; Angela M Reiersen
Journal:  JAMA       Date:  2020-12-08       Impact factor: 56.272

4.  Modulation of the sigma-1 receptor-IRE1 pathway is beneficial in preclinical models of inflammation and sepsis.

Authors:  Dorian A Rosen; Scott M Seki; Anthony Fernández-Castañeda; Rebecca M Beiter; Jacob D Eccles; Judith A Woodfolk; Alban Gaultier
Journal:  Sci Transl Med       Date:  2019-02-06       Impact factor: 17.956

5.  Variations in apolipoprotein D and sigma non-opioid intracellular receptor 1 genes with relation to risk, severity and outcome of ischemic stroke.

Authors:  Håkan Lövkvist; Ann-Cathrin Jönsson; Holger Luthman; Katarina Jood; Christina Jern; Tadeusz Wieloch; Arne Lindgren
Journal:  BMC Neurol       Date:  2014-09-28       Impact factor: 2.474

6.  Genomewide Association Study of Severe Covid-19 with Respiratory Failure.

Authors:  David Ellinghaus; Frauke Degenhardt; Luis Bujanda; Maria Buti; Agustín Albillos; Pietro Invernizzi; Javier Fernández; Daniele Prati; Guido Baselli; Rosanna Asselta; Marit M Grimsrud; Chiara Milani; Fátima Aziz; Jan Kässens; Sandra May; Mareike Wendorff; Lars Wienbrandt; Florian Uellendahl-Werth; Tenghao Zheng; Xiaoli Yi; Raúl de Pablo; Adolfo G Chercoles; Adriana Palom; Alba-Estela Garcia-Fernandez; Francisco Rodriguez-Frias; Alberto Zanella; Alessandra Bandera; Alessandro Protti; Alessio Aghemo; Ana Lleo; Andrea Biondi; Andrea Caballero-Garralda; Andrea Gori; Anja Tanck; Anna Carreras Nolla; Anna Latiano; Anna Ludovica Fracanzani; Anna Peschuck; Antonio Julià; Antonio Pesenti; Antonio Voza; David Jiménez; Beatriz Mateos; Beatriz Nafria Jimenez; Carmen Quereda; Cinzia Paccapelo; Christoph Gassner; Claudio Angelini; Cristina Cea; Aurora Solier; David Pestaña; Eduardo Muñiz-Diaz; Elena Sandoval; Elvezia M Paraboschi; Enrique Navas; Félix García Sánchez; Ferruccio Ceriotti; Filippo Martinelli-Boneschi; Flora Peyvandi; Francesco Blasi; Luis Téllez; Albert Blanco-Grau; Georg Hemmrich-Stanisak; Giacomo Grasselli; Giorgio Costantino; Giulia Cardamone; Giuseppe Foti; Serena Aneli; Hayato Kurihara; Hesham ElAbd; Ilaria My; Iván Galván-Femenia; Javier Martín; Jeanette Erdmann; Jose Ferrusquía-Acosta; Koldo Garcia-Etxebarria; Laura Izquierdo-Sanchez; Laura R Bettini; Lauro Sumoy; Leonardo Terranova; Leticia Moreira; Luigi Santoro; Luigia Scudeller; Francisco Mesonero; Luisa Roade; Malte C Rühlemann; Marco Schaefer; Maria Carrabba; Mar Riveiro-Barciela; Maria E Figuera Basso; Maria G Valsecchi; María Hernandez-Tejero; Marialbert Acosta-Herrera; Mariella D'Angiò; Marina Baldini; Marina Cazzaniga; Martin Schulzky; Maurizio Cecconi; Michael Wittig; Michele Ciccarelli; Miguel Rodríguez-Gandía; Monica Bocciolone; Monica Miozzo; Nicola Montano; Nicole Braun; Nicoletta Sacchi; Nilda Martínez; Onur Özer; Orazio Palmieri; Paola Faverio; Paoletta Preatoni; Paolo Bonfanti; Paolo Omodei; Paolo Tentorio; Pedro Castro; Pedro M Rodrigues; Aaron Blandino Ortiz; Rafael de Cid; Ricard Ferrer; Roberta Gualtierotti; Rosa Nieto; Siegfried Goerg; Salvatore Badalamenti; Sara Marsal; Giuseppe Matullo; Serena Pelusi; Simonas Juzenas; Stefano Aliberti; Valter Monzani; Victor Moreno; Tanja Wesse; Tobias L Lenz; Tomas Pumarola; Valeria Rimoldi; Silvano Bosari; Wolfgang Albrecht; Wolfgang Peter; Manuel Romero-Gómez; Mauro D'Amato; Stefano Duga; Jesus M Banales; Johannes R Hov; Trine Folseraas; Luca Valenti; Andre Franke; Tom H Karlsen
Journal:  N Engl J Med       Date:  2020-06-17       Impact factor: 91.245

7.  Homozygous L-SIGN (CLEC4M) plays a protective role in SARS coronavirus infection.

Authors:  Vera S F Chan; Kelvin Y K Chan; Yongxiong Chen; Leo L M Poon; Annie N Y Cheung; Bojian Zheng; Kwok-Hung Chan; William Mak; Hextan Y S Ngan; Xiaoning Xu; Gavin Screaton; Paul K H Tam; Jonathan M Austyn; Li-Chong Chan; Shea-Ping Yip; Malik Peiris; Ui-Soon Khoo; Chen-Lung S Lin
Journal:  Nat Genet       Date:  2005-12-20       Impact factor: 38.330

8.  Reduced prevalence of SARS-CoV-2 infection in ABO blood group O.

Authors:  Mike Bogetofte Barnkob; Anton Pottegård; Henrik Støvring; Thure Mors Haunstrup; Keld Homburg; Rune Larsen; Morten Bagge Hansen; Kjell Titlestad; Bitten Aagaard; Bjarne Kuno Møller; Torben Barington
Journal:  Blood Adv       Date:  2020-10-27

9.  Reissuing the sigma receptors for SARS-CoV-2.

Authors:  Umit Haluk Yesilkaya; Yasin Hasan Balcioglu; Serhat Sahin
Journal:  J Clin Neurosci       Date:  2020-08-11       Impact factor: 1.961

10.  Insights into the biased activity of dextromethorphan and haloperidol towards SARS-CoV-2 NSP6: in silico binding mechanistic analysis.

Authors:  Preeti Pandey; Kartikay Prasad; Amresh Prakash; Vijay Kumar
Journal:  J Mol Med (Berl)       Date:  2020-09-23       Impact factor: 4.599

View more
  3 in total

Review 1.  Effects of selected inherited factors on susceptibility to SARS-CoV-2 infection and COVID-19 progression.

Authors:  J A Hubacek
Journal:  Physiol Res       Date:  2021-12-16       Impact factor: 1.881

2.  Genetic polymorphisms associated with susceptibility to COVID-19 disease and severity: A systematic review and meta-analysis.

Authors:  Cristine Dieter; Letícia de Almeida Brondani; Cristiane Bauermann Leitão; Fernando Gerchman; Natália Emerim Lemos; Daisy Crispim
Journal:  PLoS One       Date:  2022-07-06       Impact factor: 3.752

3.  Cross-National Variations in COVID-19 Mortality: The Role of Diet, Obesity and Depression.

Authors:  Ravi Philip Rajkumar
Journal:  Diseases       Date:  2021-05-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.